203 related articles for article (PubMed ID: 22306105)
1. Complementing antibody profiles: assessing antibody function on antigen microarrays.
Prechl J; Szittner Z; Papp K
Immunol Lett; 2012 Mar; 143(1):101-5. PubMed ID: 22306105
[TBL] [Abstract][Full Text] [Related]
2. Characterization of factors influencing on-chip complement activation to optimize parallel measurement of antibody and complement proteins on antigen microarrays.
Papp K; Végh P; Hóbor R; Erdei A; Prechl J
J Immunol Methods; 2012 Jan; 375(1-2):75-83. PubMed ID: 22000977
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
Kievits F; Kijlstra A
Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
[TBL] [Abstract][Full Text] [Related]
4. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
Miletic VD; Hester CG; Frank MM
J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
[TBL] [Abstract][Full Text] [Related]
5. [Role of the complement C3 protein in the control of the specific immune response].
Villiers CL; Villiers MB; Marche PN
Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739
[TBL] [Abstract][Full Text] [Related]
6. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
7. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
Garred P; Michaelsen TE; Aase A; Mollnes TE
J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
[TBL] [Abstract][Full Text] [Related]
8. The immunological aspects of sickle cell syndrome with particular reference to circulating immune complexes.
Kazeem AA
East Afr Med J; 1990 Nov; 67(11):761-9. PubMed ID: 2076676
[TBL] [Abstract][Full Text] [Related]
9. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
10. Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.
Rajnavölgyi E; Fazekas G; Lund J; Daeron M; Teillaud JL; Jefferis R; Fridman WH; Gergely J
Immunology; 1995 Apr; 84(4):645-52. PubMed ID: 7540592
[TBL] [Abstract][Full Text] [Related]
11. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
12. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.
Zachrau B; Finke D; Kropf K; Gosink HJ; Kirchner H; Goerg S
Int Immunol; 2004 Dec; 16(12):1685-90. PubMed ID: 15477230
[TBL] [Abstract][Full Text] [Related]
13. Immune complex signatures of patients with active and inactive SLE revealed by multiplex protein binding analysis on antigen microarrays.
Papp K; Végh P; Hóbor R; Szittner Z; Vokó Z; Podani J; Czirják L; Prechl J
PLoS One; 2012; 7(9):e44824. PubMed ID: 22984570
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
15. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
16. Isotype and glycoform selection for antibody therapeutics.
Jefferis R
Arch Biochem Biophys; 2012 Oct; 526(2):159-66. PubMed ID: 22465822
[TBL] [Abstract][Full Text] [Related]
17. Complement activation by IgG containing immune complexes regulates the interaction of C1q with its ligands.
Hester CG; Frank MM
Mol Immunol; 2019 Dec; 116():117-130. PubMed ID: 31634815
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal rheumatoid factor-IgG immune complexes. Poor fixation of opsonic C4 and C3 despite efficient complement activation.
Ng YC; Peters DK; Walport MJ
Arthritis Rheum; 1988 Jan; 31(1):99-107. PubMed ID: 3345233
[TBL] [Abstract][Full Text] [Related]
19. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
[TBL] [Abstract][Full Text] [Related]
20. Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages.
Daha MR; Van Es LA
Immunology; 1981 Jul; 43(3):513-8. PubMed ID: 7251062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
